These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 372622)

  • 21. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
    Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
    J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microtitration method for determining von Willebrand's factor in the plasma of acute myocardial infarct patients].
    Bespal'ko IA
    Lab Delo; 1985; (12):718-22. PubMed ID: 2418266
    [No Abstract]   [Full Text] [Related]  

  • 23. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases].
    Dulhoste MN; Bonnet J; Vergnes C; Choussat A; Bricaud H
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1875-8. PubMed ID: 2514640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesive platelet count and blood coagulability in myocardial infarction and cerebral thrombosis.
    Yamazaki H; Odakura T; Takeuchi K; Sano T
    Thromb Diath Haemorrh; 1970 Dec; 24(3):450-60. PubMed ID: 5503942
    [No Abstract]   [Full Text] [Related]  

  • 26. [Platelet adhesion and aggregation].
    David JL
    Acta Clin Belg; 1977; 32(6):363-74. PubMed ID: 211769
    [No Abstract]   [Full Text] [Related]  

  • 27. [Molecular markers of thrombosis and their clinical significance].
    Pan JY; Zhang ZN
    Zhonghua Nei Ke Za Zhi; 1990 Jul; 29(7):395-7. PubMed ID: 2282867
    [No Abstract]   [Full Text] [Related]  

  • 28. New insights into the mechanisms of platelet adhesion and aggregation.
    Ruggeri ZM
    Semin Hematol; 1994 Jul; 31(3):229-39. PubMed ID: 7973779
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet function tests in acute myocardial infarction.
    Singh A; Gupta OP; Sangha HK
    Indian Heart J; 1980; 32(1):25-9. PubMed ID: 7380452
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of activity of ristocetin cofactor in blood using the coagulation time meter KZM-1].
    Lutze G; Töpfer G; Urbahn H
    Z Med Lab Diagn; 1983; 24(3):139-48. PubMed ID: 6604377
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of the von Willebrand factor in the physiopathology of primary hemostasis].
    Dmoszyńska-Giannopoulou A
    Pol Tyg Lek; 1983 Nov; 38(48):1519-21. PubMed ID: 6089153
    [No Abstract]   [Full Text] [Related]  

  • 32. A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease.
    Bowyer AE; Shepherd F; Kitchen S; Makris M
    Thromb Res; 2011 Apr; 127(4):341-4. PubMed ID: 21186048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Von Willebrand factor. Its role in hemostasis and the method of its determination].
    Baluda VP; Sushkevich GN
    Lab Delo; 1976; (8):451-5. PubMed ID: 66393
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a flow-through system to create occluding thrombus.
    Ku DN; Flannery CJ
    Biorheology; 2007; 44(4):273-84. PubMed ID: 18094451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet function tests and thrombosis.
    O'Brien JR
    Adv Exp Med Biol; 1972; 34():43-54. PubMed ID: 4565966
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biological diagnosis of von Willebrand's disease (author's transl)].
    Castillo R; Maragall S; Liendo F; Ordinas A
    Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168
    [No Abstract]   [Full Text] [Related]  

  • 37. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemostatic changes in idiopathic venous thrombosis in childhood and adolescence].
    Nowak-Göttl U; Kreuz WD; Hach-Wunderle V; Freund H; Güngör T; Ehrenforth S; Breddin HK; Kornhuber B
    Klin Padiatr; 1991; 203(6):424-8. PubMed ID: 1758145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
    Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
    Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.